Journal of Endoluminal Endourology最新文献

{"title":"Renal Metastasis from Submandibular Gland Adenocarcinoma First Reported Patient in Literature History","authors":"M. Ahmed, N. Tofazzal, R. Nirula, J. Thomas, A. Dhanasekaran","doi":"10.22374/JELEU.V2I3.30","DOIUrl":"https://doi.org/10.22374/JELEU.V2I3.30","url":null,"abstract":"This paper presents a patient of primary submandibular gland adenocarcinoma later presenting with renal metastasis. Renal cancers are known for its predisposition to unusual metastasis to other organs. On the contrary, renal metastasis from salivary gland tumours are extremely rare with none reported from the submandibular gland to date. Hence the significance of adequate history taking, immunohistochemical identification of pathology and multidisciplinary approach in the management of such rare clinical presentation is discussed here. Metastatic disease should always be a differential when evaluating cancer patients regardless of the interval since previous disease or rarity of occurrence.","PeriodicalId":136362,"journal":{"name":"Journal of Endoluminal Endourology","volume":"62 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114439332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Spindle Cell Lipoma of Scrotum","authors":"M. Iqbal, S. Agarwal, I. Shergill","doi":"10.22374/JELEU.V2I2.46","DOIUrl":"https://doi.org/10.22374/JELEU.V2I2.46","url":null,"abstract":"Spindle cell lipoma (SCL) in the scrotum is a very rare presentation with only a few cases reported in the literature. The most common sites for this benign lesion are the neck, shoulder, and back. We present a 72-year-old male patient with painless swelling on the left half of the scrotum with a histopathological diagnosis of SCL.","PeriodicalId":136362,"journal":{"name":"Journal of Endoluminal Endourology","volume":"7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133223243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Retrospective Audit of the TURBT Quality in Two Major Cancer Centres in Lancashire","authors":"K. Hosny, Jennifer Clark, M. Nosseir, M. Al-Attar, Mohammad Masaarane, N. Cockburn, Izzati Samsudin","doi":"10.22374/JELEU.V2I2.41","DOIUrl":"https://doi.org/10.22374/JELEU.V2I2.41","url":null,"abstract":"Transurethral resection of bladder tumour (TURBT) is the first step in management of bladder cancers. A urology trainee in the UK must do at least 120 procedures during their training years before being a consultant. In our article, we are reporting a retrospective audit of the quality of TURBT across 2 major cancer centres in Lancashire. We assessed the adherence of surgical procedure to the national and international guidelines among different grades of urological surgeons who work in the 2 trusts.","PeriodicalId":136362,"journal":{"name":"Journal of Endoluminal Endourology","volume":"38 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132972279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of Efficacy and Safety between Post-operative Intra-vesical Instillation of Mitomycin-C and Continuous Saline Bladder Irrigation (CSBI) after TURBT in Non-muscle Invasive Bladder Cancers","authors":"A. Bhat, Z. Bhat","doi":"10.22374/JELEU.V2I2.40","DOIUrl":"https://doi.org/10.22374/JELEU.V2I2.40","url":null,"abstract":"ObjectiveTo critically analyse the efficacy and safety of continuous saline bladder irrigation versus single installation of mitomycin-C (MMC) after transurethral resection of bladder tumour (TURBT) in patients with low to intermediate risk non-muscle invasive bladder cancer. \u0000Materials and MethodsThe question in consideration best merits answer by critically reviewing and analyzing the literature and finally to provide the recommendation about the relevance of the conclusions from the literature. A search study identifies the relevant literature from the well-known academic databases in the context of the re-search question. The particular sets of the key words are used in different formats to search the literature. The literature has been thoroughly reviewed and analyzed for the strengths and limitations. Specific data was critically taken for analysis depending upon the type of literature articles with special reference to their usefulness, knowledge, attitudes, transferability, validity/reliability and strength of conclusions. \u0000ResultsA total of 6 papers meeting the inclusion criteria, which compared the results of the efficacy and safety between intravesical chemotherapy and continuous saline bladder irrigation (CSBI) were critically analyzed. ConclusionCSBI cannot replace MMC in terms of its efficacy in the prevention of recurrence and progression but because of the better safety profile can be used as an alternative in patients with low to intermediate risk bladder cancers after TURBT.","PeriodicalId":136362,"journal":{"name":"Journal of Endoluminal Endourology","volume":"48 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122830489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Connecting the Urological Community : The #UroSoMe Experience","authors":"Kalyan Gudaru, L. T. Blanco, D. Castellani, Hegel Trujillo Santamaria, M. Pelayo-Nieto, E. Linden‐Castro, M. Wroclawski, Mateus Cosentino Bellote, J. Inarritu, R. D. da Silva, V. Gauhar, Zainal Adwin, J. Teoh","doi":"10.22374/JELEU.V2I2.44","DOIUrl":"https://doi.org/10.22374/JELEU.V2I2.44","url":null,"abstract":"Background and Objectives \u0000There is an increasing use of social media amongst the urological community. However, it is difficult to identify urological data on various social media platforms in an efficient manner. We proposed a hashtag, #UroSoMe, to be used when posting urology-related content in the social media platforms. The objectives of this article are to describe how #UroSoMe was developed, and to report the data of the first month of #UroSoMe. \u0000  \u0000Material and Methods \u0000The hashtag, #UroSoMe, was introduced to the urological community. The #UroSoMe working group was formed, and the members actively invited and encouraged people to use the hashtag #UroSoMe when posting urology-related contents. After the #UroSoMe (@so_uro) platform on twitter had grown to more than 300 users, the first live event of online case discussion, i.e. #LiveCaseDiscussions, was conducted. A prospective observational study of the hashtag #UroSoMe Twitter activity during the first month of its usage from 14 December 2018 to 13 January 2019 was evaluated. Outcome measures included number of users, number of tweets, user location, top tweeters, top hashtags used and interactions. Analysis was performed using NodeXL (Social Media Research Foundation; California, USA; https://www.smrfoundation.org/nodexl/), Symplur (https:// www.symplur.com) and Twitonomy (https://www.twitonomy.com). \u0000  \u0000Results \u0000The first month of #UroSoMe activity documented 1373 tweets/retweets by 1008 tweeters with 17698 mentions and 1003 replies. The #LiveCaseDiscussions was able to achieve a potential reach of 2,033,352 Twitter users. The top tweets mainly included cases presented by #UroSoMe working group members during #LiveCaseDiscussions. The twitonomy map showed participation from 214 geographical locations. The major groups of participants using the hashtag #UroSoMe were ‘Researcher/Academic’ and ‘Doctor’. The twitter account of #UroSoMe (@so_uro) has now grown to more than 1000 followers. \u0000  \u0000Conclusions \u0000Social media is an excellent platform for interaction amongst the urological community. The results demonstrated that #UroSoMe was able to achieve wide spread engagement from all over the world.","PeriodicalId":136362,"journal":{"name":"Journal of Endoluminal Endourology","volume":"109 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117217081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Review of IPSS Questionnaire in Postoperative Transurethral Resection of Prostate (TURP) for Streamlining Follow-up Protocols","authors":"G. Broadley, G. Delves, S. Khwaja","doi":"10.22374/JELEU.V2I2.36","DOIUrl":"https://doi.org/10.22374/JELEU.V2I2.36","url":null,"abstract":"ObjectiveClarify the role of IPSS questionnaire for post TURP operation patients, to assess and streamline best follow-up protocols \u0000Materials and MethodsWe identified 87 consecutive patients over 6 months undergoing standardized bipolar TURP. We retro-spectively reviewed patients at 3 months in follow-up clinic, where we performed tests including Qmax, Post-void residual (PVR) and IPSS (International Prostate Symptom Score). We identified patients who were discharged or underwent a change in standard management at this point, and used ROC (Receiver Operating Curve) curve analysis to identify the tools which showed the best ability to predict this decision. ResultsROC curve analysis suggested Qmax (AUC: 0.7751) and IPSS (AUC 0.8571) were the best tools to predict a change in management. Given the IPSS tool is a questionnaire, thus holding most promise to streamline protocols, we applied Youden-J test to show IPSS=8 cut-off was best to identify management changes. \u0000ConclusionThe IPSS tool is able to predict a need for change in management in post TURP patients at 3 months. This will allow a simple triage system to provide an efficient and effective decision-making process for discharge without the need for clinic attendance.","PeriodicalId":136362,"journal":{"name":"Journal of Endoluminal Endourology","volume":"207 ","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114004193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Systematic Review and Single-Centre Experience of Ureterorenoscopy Under Local Anesthetic: A Safer Option for Anesthetically High-Risk Patients?","authors":"A. Tasleem, S. Yallappa, M. Mikhail, T. Amer, Peter Pietrzak, P. Acher, A. Young","doi":"10.22374/JELEU.V2I2.39","DOIUrl":"https://doi.org/10.22374/JELEU.V2I2.39","url":null,"abstract":"Patients are living longer with an increasing number of co-morbidities. Minimally invasive ureterorenoscopy (URS) to manage upper tract calculi or transitional cell carcinoma (TCC) can be performed under general or spinal anaesthesia, however certain co-morbid patients are not suitable for this and may benefit from a different approach. We report on URS under local anaesthesia (LA) using intra-ureteric marcaine as the primary form of anaesthesia. We also aimed to perform a robust systematic review of this topic. \u0000  \u0000A retrospective analysis over 6 years was undertaken on all patients who underwent URS for calculi or TCC under LA, with the use of intra-urethral lidocaine gel (2%) and intra-ureteric marcaine (0.5%, 20ml) with sedoanalgesia as an adjunct. A systematic review and all English Language articles on ureteroscopic procedures with the use of LA with or without intravenous sedoanalgesia were selected and data extracted. \u0000  \u0000In our case series, twelve patients had a total of 42 procedures. Stone size varied from 4-35mm. Twenty-two percent of procedures (9/41) did not require any sedation or intravenous analgesia as an adjunct to the bupivacaine with a further 49% (20/41) requiring midazolam. (The anaesthetic chart was not available for one procedure). No procedures were abandoned and there were no conversions to general/spinal anaesthesia. There were no complications secondary to the use of LA. Eighty-one percent of cases (34/42) were performed as day-case or overnight stays. The complication rate was similar to that for conventional anaesthesia. The systematic review yielded 1121 procedures from 11 papers and 7 countries. In 32 cases the procedure was converted to general anaesthesia.  Stone clearance rates were between 78-100%. The procedures were well tolerated in 80-90% of cases. \u0000  \u0000This study highlights that URS can be safely performed under LA. It is well tolerated and represents an option for carefully selected patients who have been adequately counselled, and who would be at high risk from anaesthesia. Such patients may otherwise be considered “unfit” for endourological intervention. \u0000  \u0000 ","PeriodicalId":136362,"journal":{"name":"Journal of Endoluminal Endourology","volume":"102 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133253249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Holmium Laser Treatment of an Obstructive Ureterocele in an Adult Patient: A Case Report and Video","authors":"O. Abdalla, Y. C. Phan, S. Sriprasad","doi":"10.22374/JELEU.V2I1.27","DOIUrl":"https://doi.org/10.22374/JELEU.V2I1.27","url":null,"abstract":"Adult Ureteroceles are uncommon, majority of which are asymptomatic and commonly found incidentally. Surgical deroofing is indicated in patients with bothersome symptoms or complications secondary to ureteroceles. Several deroofing techniques has been described in the literature including nephroscopic scissors, collin's knife, and use of lasers in the last two decades became popular.  Herein we report a case and demonstare our technique of using Holmium laser to treat an adult with symptomatic obstructive unilateral ureterocele. ","PeriodicalId":136362,"journal":{"name":"Journal of Endoluminal Endourology","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115007015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Thulium Laser Vaporization versus Vapoenucleation (without morcellation) Technique for BPH: Do We Have a Winner?","authors":"D. Sarma, Y. Singh, S. J. Baruah, T. P. Rajeev, S. Barua, P. K. Bagchi, Mandeep Phukan, M. Kashyap","doi":"10.22374/jeleu.v2i1.26","DOIUrl":"https://doi.org/10.22374/jeleu.v2i1.26","url":null,"abstract":"Background and ObjectiveThe thulium laser surgery is a relatively new approach in which a wavelength of approximately 2 μm is emitted in continuous-wave mode, thus enabling the precise incision of tissue by using a wavelength that matches the water absorption peak of 1.92 μm in tissue. However, no published multinational study or other evidence definitively declares the superiority of thulium vaporization (ThuVAP) over thulium vapoenucle-ation (ThuVEP) without morcellator for better management of bothersome benign prostatic hyperplasia. The present study aims to evaluate the efficacy of vaporization and vapoenucleation (without a morcellator) in thulium laser prostatectomy for the treatment of benign prostatic hyperplasia.MethodsA retrospective analysis of 82 patients who underwent thulium laser prostatectomy between February 2017 and January 2018 with ThuVAP and ThuVEP techniques was done and outcome measures analyzed were International Prostate Symptom Score (IPSS), quality-of-life score (QoL), maximum flow rate (Q max), post-void residual (PVRU), total operating time, laser time and resected tissue weight.ResultsNo significant differences were noted between ThuVAP and ThuVEP in terms of post-operative prostate volume (22.4 vs. 21.7 mL) and post-operative prostate specific antigen (PSA) (2.54 vs. 1.85 ng/mL). Nonetheless, there were differences between the groups in total lasing time (56.5 vs. 44.8 min, p = 0.001) and total operative time (88.5 vs. 71.5 min, p= 0.001). There was also a significant difference in IPSS, QoL score, Q max, and PVRU at 6 weeks, 3 months, 6 months and 9 months after surgery.","PeriodicalId":136362,"journal":{"name":"Journal of Endoluminal Endourology","volume":"31 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134540558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Novel Surgical Treatments for Benign Prostatic Hyperplasia","authors":"Blessing Dhliwayo, S. Mukhtar","doi":"10.22374/JELEU.V2I1.29","DOIUrl":"https://doi.org/10.22374/JELEU.V2I1.29","url":null,"abstract":"Transurethral resection of the prostate (TURP) has been the gold standard for the treatment of elderly men with lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH). However, over the last few years, advances in surgical treatment have led to the development of other treatment modalities. These innovations include convective WAter Vapor Energy (WAVE; Rezum System), prostatic urethral lift (PUL; UroLift System), Prostate Artery Embolisation (PAE) and Aquablation (AQUABEAM System). This review provides an update on these current minimal invasive surgical treatments. The evidence of their safety, tolerability and efficacy in clinical practice is reviewed.","PeriodicalId":136362,"journal":{"name":"Journal of Endoluminal Endourology","volume":"67 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125170838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}